David whitehouse, mD
David Whitehouse, MD is an accomplished Senior Executive with demonstrated success spanning the healthcare industry. Leveraging extensive experience as a strategic, outcome-focused clinical entrepreneur with a record of innovative solutions, actionable plans, and measurable results for large companies facing competitive market challenges, Dr. Whitehouse has been a leader in the field in the areas of technological innovation in medicine, system transformation, personalized medicine, integrative neuroscience, tele-medicine, and clinical research. His broad areas of expertise include planning, population health, outcomes-focused & value-based deliverables, risk mitigation, sales, marketing, organizational alignment, and process improvements.
Dr. Whitehouse has held a number of leadership positions. At present, he serves as Independent Consultant with David Whitehouse Associates, Ltd, where he works closely as an advisor and consultant to innovative healthcare companies such as Senscio, the leading delivery system in augmented home-based monitoring and remote complex care management company, as well as Total Brain and CerraCap Ventures as it relates to the company’s health investments. Previously, Dr. Whitehouse held the titles of Chief Medical Officer (CMO) and Head of Digital Health Transformation with UST Global, a leading digital technology services company that provides powerful solutions for Global 1000 companies, helping them navigate critical digital transformations to derive higher business value. Dr. Whitehouse also acted as Executive Medical Officer and CMO with Catalyst RX (now Catamaran) and was CMO for Strategy and Innovation at Optum Health Behavioral Solutions. He was responsible for increasing revenue by 300% during his tenure at each, while guiding the development of the first use of avatars in the mobile health space. He is a frequent presenter at industry conferences, as well as broadcast media and publications including a regular column in the past for DMEC.
Dr. Whitehouse holds an MD from the Geisel School of Medicine at Dartmouth, a ThM and ThD in Religion from Harvard University, an MBA from the University of Connecticut and both a BA and MA in Medicine and Theology from the University of Cambridge. Dr. Whitehouse is a seasoned board member, who has served on a number of other BODs including brainNet, TaoConnect, CerraCap, PSI International, Spring Health, and Vivace.
Kevin R. Hawkins, ph.D.
Kevin R. Hawkins, Ph.D. has 25 years of experience designing, conducting, and managing health services research. Dr. Hawkins has contributed to a variety of research and evaluation projects, specifically health-economic, quality-of-life, disease burden, pharmacoeconomics and retrospective database analyses. Dr. Hawkins has authored over 100 peer-reviewed articles and presentations, and is a reviewer for several medical-scientific journals. Before joining PharmD Live, Dr. Hawkins worked for Optum, IMS Health, Medstat, and Blue Cross Blue Shield of Michigan. Dr. Hawkins received his Ph.D. in Health Economics from Wayne State University.